|
CENPI expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.56600004869767E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.67640000051195E-07 |
| Normal-vs-Stage2 |
5.776100E-04 |
| Normal-vs-Stage3 |
1.217220E-04 |
| Normal-vs-Stage4 |
2.216400E-04 |
| Stage1-vs-Stage2 |
7.007200E-01 |
| Stage1-vs-Stage3 |
1.958590E-01 |
| Stage1-vs-Stage4 |
1.192400E-02 |
| Stage2-vs-Stage3 |
1.664990E-01 |
| Stage2-vs-Stage4 |
1.030500E-02 |
| Stage3-vs-Stage4 |
7.240200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.83790016328578E-10 |
| Normal-vs-AfricanAmerican |
1.882100E-02 |
| Normal-vs-Asian |
2.483400E-01 |
| Caucasian-vs-AfricanAmerican |
1.842390E-03 |
| Caucasian-vs-Asian |
5.582200E-01 |
| AfricanAmerican-vs-Asian |
3.562600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.39080000241643E-08 |
| Normal-vs-Female |
4.20590000049792E-07 |
| Male-vs-Female |
2.472200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.601500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.58560000002228E-06 |
| Normal-vs-Age(61-80Yrs) |
7.25350000063685E-08 |
| Normal-vs-Age(81-100Yrs) |
4.212300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.660400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.389800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.145700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.500000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.036100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.393800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.095700E-02 |
| Normal-vs-Grade 2 |
7.16700000014114E-07 |
| Normal-vs-Grade 3 |
3.81190000009468E-07 |
| Normal-vs-Grade 4 |
5.582200E-04 |
| Grade 1-vs-Grade 2 |
3.314600E-01 |
| Grade 1-vs-Grade 3 |
7.472500E-02 |
| Grade 1-vs-Grade 4 |
8.699900E-03 |
| Grade 2-vs-Grade 3 |
1.980560E-01 |
| Grade 2-vs-Grade 4 |
1.609960E-02 |
| Grade 3-vs-Grade 4 |
4.058100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.54543999999479E-05 |
| Normal-vs-ccB subtype |
4.51739999962619E-07 |
| ccA subtype-vs-ccB subtype |
6.997600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59030000002058E-06 |
| Normal-vs-N1 |
2.104500E-03 |
| N0-vs-N1 |
2.549700E-02 |
|
|
